Alpha-glucans and beta-glucans are both long chains of glucose (a simple sugar) built by mushrooms and other organisms. The difference is in how the glucose units are linked together chemically. Beta-glucans use “beta” bonds that the human body cannot fully digest, which is why they behave more like dietary fiber and are the polysaccharide type most studied for immune-related activity. Alpha-glucans use “alpha” bonds — the same basic linkage found in starch — which the body can break down and use more like a carbohydrate. Many mushrooms and mushroom products contain a mix of both.
This article explains what current research says about alpha-glucans specifically, how that evidence compares to the much larger body of beta-glucan research, and what that difference means for anyone reading a mushroom supplement label.
Quick Answer: Are Alpha-Glucans and Beta-Glucans the Same Thing?
No. They are both classified as polysaccharides (long sugar-chain molecules) and often show up in the same mushroom species, but they are structurally different compounds studied for different reasons. Beta-glucans, especially the 1,3/1,6-linked forms, are the compounds behind most published mushroom-and-immune-function research. Alpha-glucans have a smaller, mostly preclinical research base and are structurally closer to starch than to fiber.
How the Two Compound Types Compare
- Chemical bond type: Beta-glucans use beta-glycosidic linkages; alpha-glucans use alpha-glycosidic linkages, the same bond type found in starch.
- Digestibility: Human digestive enzymes largely cannot break down beta-glucan bonds, so beta-glucans pass through much of the digestive tract intact. Alpha-glucan bonds are closer to the ones human enzymes are built to digest.
- Research volume: Beta-glucans have a large, decades-long research base, including some human clinical trials. Alpha-glucan research on mushrooms is smaller and comes mostly from laboratory and animal studies.
- Best-studied example: Beta-glucan-linked compounds called PSK and PSP, derived from turkey tail mushroom, have the strongest human evidence of any mushroom polysaccharide. There is no alpha-glucan compound with a comparable human evidence record.
- Label accuracy issue: Some standard laboratory tests used for supplement labels do not fully separate alpha-glucans from beta-glucans. This matters because mycelium (the root-like part of a fungus) grown on a grain substrate such as rice can retain starch-derived alpha-glucans from that grain, which can inflate the “polysaccharide” or “beta-glucan” number printed on a label without reflecting truly mushroom-derived, immune-active material.
What Research Actually Shows About Alpha-Glucans
Alpha-glucans from specific mushroom species have been studied mainly in laboratory and animal research, not in human clinical trials. For example, an alpha-glucan isolated from maitake mushroom (Grifola frondosa) has been studied in mouse models of type 2 diabetes for possible effects on pancreatic cells. This is preclinical, animal-only evidence. It has not been confirmed in human trials, and it does not show that a maitake supplement can affect blood sugar in people.
Structural studies of other species have found that a single mushroom can contain several polysaccharide types side by side — for instance, one wild species has been documented containing an alpha-glucan alongside two separate beta-glucan structures in the same fruiting body. This kind of finding helps explain why “polysaccharide content” alone, without specifying alpha or beta, tells a reader very little about a product’s likely activity.
Bottom line on alpha-glucans: the honest, current answer is that alpha-glucan research in mushrooms is early-stage, preclinical, and not yet a basis for any health claim in people.
What Research Shows About Beta-Glucans, for Comparison
Beta-glucans are the polysaccharide type most linked to mushroom immune research, and one form has meaningfully more human data than any alpha-glucan. PSK (polysaccharide-K, sold in Japan under the brand name Krestin) is a beta-glucan-linked compound derived from turkey tail mushroom. According to the National Cancer Institute, PSK has been studied in randomized human clinical trials in patients with gastric, colorectal, and lung cancers, where it was combined with standard chemotherapy — not used alone or in healthy people. Some of those trials reported improved survival or reduced recurrence when PSK was added to standard treatment. PSK has been approved for use in Japan since the mid-1970s, but it is not approved by the FDA for use as a cancer treatment in the United States, and it is not the same product as an over-the-counter turkey tail supplement.
This distinction matters: even the best-researched mushroom polysaccharide is a pharmaceutical-grade extract studied as an add-on to conventional cancer treatment under medical supervision — not a general wellness claim that applies to retail supplements.
Reading a Mushroom Supplement Label: A Quick Checklist
- Does the label specify “beta-glucan” content separately from total “polysaccharide” content? A vague “polysaccharide” number alone can include starch-like alpha-glucans.
- Does the product state whether it is made from fruiting body, mycelium, or a grain-based mycelium product? Grain-based mycelium products are more likely to contain non-mushroom, starch-derived alpha-glucans.
- Does the company disclose its testing method for beta-glucan content? Third-party testing that separates alpha- and beta-glucans is a stronger signal than a single blended number.
- Is the product being marketed for a specific medical outcome (treating, curing, or preventing a disease)? Under U.S. law, dietary supplements cannot legally make that claim, and no mushroom supplement is FDA-approved to do so.
Evidence Limits and Extra-Caution Groups
Alpha-glucan research in mushrooms is limited almost entirely to laboratory and animal studies. Beta-glucan research includes some human clinical trials, but the strongest of that evidence involves pharmaceutical-grade extracts (like PSK) used alongside standard cancer treatment under a doctor’s care — not general-purpose supplements taken on their own. Neither compound type should be treated as a substitute for medical diagnosis or treatment.
People in the following groups should talk with a qualified clinician before starting any mushroom-derived polysaccharide supplement, since these compounds are studied for immune-related activity:
- Anyone taking immunosuppressant medication or with an autoimmune condition
- Anyone currently undergoing chemotherapy or radiation, or scheduled for surgery
- Anyone with a known mushroom, mold, or fungal allergy
- Pregnant or breastfeeding individuals
- Anyone already taking prescription medication, due to possible interactions
Frequently Asked Questions
Are alpha-glucans bad for you?
No evidence suggests mushroom-derived alpha-glucans are harmful in normal dietary amounts. The concern raised by researchers and testing labs is about label accuracy and product transparency, not safety.
Can alpha-glucans boost the immune system like beta-glucans do?
That has not been established in human research. Most immune-related mushroom research focuses on beta-glucans. Alpha-glucan studies to date are laboratory and animal-based and have looked at other areas, such as blood sugar in mice, not confirmed human immune effects.
Why do some supplement labels list “beta-glucan” percentages that seem very high?
Some standard test methods do not fully distinguish alpha-glucans from beta-glucans, and grain-based mycelium products can contain starch-derived alpha-glucans from the growing substrate. This can make a printed “beta-glucan” or “polysaccharide” number look higher than the amount of true, mushroom-derived, immune-active material actually present.
Is PSK from turkey tail the same as an over-the-counter turkey tail supplement?
No. PSK is a pharmaceutical-grade extract studied in clinical trials and used in Japan alongside standard cancer treatment. It is not FDA-approved in the United States, and it differs in manufacturing, standardization, and testing from retail turkey tail supplements sold as dietary supplements.
Related Reading on This Site
- Beta-Glucans in Mushrooms: Immune Research, Structure and What Evidence Shows
- Mushroom Beta-Glucans and Polysaccharides: What Blood Sugar Research at the Compound Level Shows
- PSK and PSP: Turkey Tail Polysaccharides in Cancer Adjunctive Research
- Mushrooms and Immune Function: Cross-Species Research Summary
Educational Disclaimer
This article is for educational purposes only and is not medical advice. It does not diagnose any condition, recommend any treatment, or establish a safe or effective dose for any mushroom compound. Mushroom polysaccharides, including alpha-glucans and beta-glucans, are not approved by the FDA to treat, support, or prevent any disease. Talk with a qualified healthcare provider before starting, stopping, or changing any supplement or medication, especially if you are pregnant, breastfeeding, immunocompromised, undergoing cancer treatment, or taking prescription medication.